About Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a company based in Dublin (Ireland) founded in 1996 by Mauro Ajani. The company has 321 employees as of December 31, 2024. Cosmo Pharmaceuticals has completed 2 acquisitions, including BioXell and Cassiopea. Cosmo Pharmaceuticals operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Alcresta and Norgine, among others.
- Headquarter Dublin, Ireland
- Employees 321 as on 31 Dec, 2024
- Founders Mauro Ajani
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cosmo Pharmaceuticals Nv
-
Annual Revenue
$280.52 M (USD)181.94as on Dec 31, 2024
-
Net Profit
$140.09 M (USD)0as on Dec 31, 2024
-
EBITDA
$165.61 M (USD)1816.78as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
321
as on Dec 31, 2024
-
Investments & Acquisitions
BioXell
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a publicly listed company on the SIX with ticker symbol COPN in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Cosmo Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Cosmo Pharmaceuticals
Investors in Cosmo Pharmaceuticals
Cosmo Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invision.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Invision is engaged in providing investment and succession solutions for mid-sized companies.
|
Locked | Locked | Locked |
Investor details for Cosmo Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cosmo Pharmaceuticals
Cosmo Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include BioXell and Cassiopea.
Investment portfolio details for Cosmo Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical-stage pharma company focused on Italian dermatology treatments.
|
Locked | Locked | 2009 | Locked | |
|
Italian, clinical stage biopharma developing small molecule and antibody therapeutics for chronic inflammatory and autoimmune diseases
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Cosmo Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cosmo Pharmaceuticals
Detailed financials for Cosmo Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cosmo Pharmaceuticals Comparisons
Peer comparison for Cosmo Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cosmo Pharmaceuticals
Cosmo Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Alcresta and Norgine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| Locked | Locked | Locked |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| Locked | Locked | Locked |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
Detailed competitors of Cosmo Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cosmo Pharmaceuticals
Complete news archive for Cosmo Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cosmo Pharmaceuticals
Cosmo Pharmaceuticals was founded in 1996 and raised its 1st funding round 12 years after it was founded.
Cosmo Pharmaceuticals is headquartered in Dublin, Ireland.
As of Dec 31, 2024, the latest employee count at Cosmo Pharmaceuticals is 321.
Annual revenue of Cosmo Pharmaceuticals is $280.52M as on Dec 31, 2024.
Cosmo Pharmaceuticals was founded in 1996 in Dublin, Ireland, within the pharmaceuticals sector. Therapeutics targeting gastrointestinal diseases are developed, including Aemcolo for inflammatory bowel conditions, Byfavo for sedation in colonoscopy procedures, MethyleneBlue MMX for lesion detection during colonoscopies, and CB-03-10 for solid tumors. Additionally, GI Genius AI-enhanced software is provided to support endoscopy processes.
Cosmo Pharmaceuticals's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Yes, Cosmo Pharmaceuticals is publicly traded on SIX under the ticker symbol COPN.
Cosmo Pharmaceuticals has 1 investor. Key investors include Invision.
The ticker symbol of Cosmo Pharmaceuticals is COPN on SIX.